GJB2 and breast cancer: In order to further assess primary mammary tumors from mice in which Cx26 knockout occurred prior to DMBA treatment, mammary tumors were immunolabelled with a variety of connexin, luminal and myoepithelial markers (Figure 5A) and the percentage of cells expressing the markers were recorded (Figure 5B).